Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C8H11NO3 |
| Molecular Weight | 169.1778 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
NCC(O)C1=CC(O)=C(O)C=C1
InChI
InChIKey=SFLSHLFXELFNJZ-UHFFFAOYSA-N
InChI=1S/C8H11NO3/c9-4-8(12)5-1-2-6(10)7(11)3-5/h1-3,8,10-12H,4,9H2
| Molecular Formula | C8H11NO3 |
| Molecular Weight | 169.1778 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Norepinephrine hydrochloride, (±)- (DL-Norepinephrine Hydrochloride) is a vasoconstrictor, cardiac stimulant, α- and β-sympathomimetic agent. DL-Norepinephrine hydrochloride is an adrenergic drug. Norepinephrine is an endogenous catecholamine that is the neurotransmitter at sympathetic postganglionic fibers. It has potent beta1- and alpha-stimulating effects. In contrast to epinephrine, norepinephrine has only minor effects on beta2 receptors. The clinical effects of norepinephrine administration are mainly increased cardiac index and increased vascular (systemic and pulmonary) resistance. Several adult studies have suggested that norepinephrine is useful in increasing SVR in patients with hyperdynamic or vasodilatory septic shock that is not responsive to dopamine or epinephrine. Additionally, it can augment coronary blood flow by increasing systemic diastolic pressure, at the expense of increasing afterload.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Strategies for enantioseparations of catecholamines and structurally related compounds by capillary zone electrophoresis using sulfated beta-cyclodextrins as chiral selectors. | 2006-09 |
|
| Beta 2-adrenoceptor-mediated positive dromotropic effects on atrioventricular node of dogs. | 1992-01 |
|
| Properties of [3H]bunazosin binding in rat kidney. | 1988 |
|
| [Analysis of the vascular reactivity of isolated and blood-perfused rabbit thoracic aortas with support rabbits]. | 1987-10 |
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2989425
Curator's Comment: The functional significance of beta 2-adrenoceptors in atrioventricular (AV) nodal conduction was investigated by using canine isolated blood-perfused AV node preparations. The dose-response curve for dl-norepinephrine (0.03-1 nmol) was shifted to the right by 1.0 log unit with atenolol only. https://www.ncbi.nlm.nih.gov/pubmed/1346356
The biogenic amines DL-epinephrine, DL-norepinephrine, tyramine, DL-phenylethanolamine, 2-phenylethylamine, and dopamine, applied at concentrations of 10(-8) or 10(-4) M, do not change the MFF (maximum following frequency, MFF).
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:55:11 GMT 2025
by
admin
on
Mon Mar 31 17:55:11 GMT 2025
|
| Record UNII |
K294OAI79V
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C87053
Created by
admin on Mon Mar 31 17:55:11 GMT 2025 , Edited by admin on Mon Mar 31 17:55:11 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
K294OAI79V
Created by
admin on Mon Mar 31 17:55:11 GMT 2025 , Edited by admin on Mon Mar 31 17:55:11 GMT 2025
|
PRIMARY | |||
|
1657875
Created by
admin on Mon Mar 31 17:55:11 GMT 2025 , Edited by admin on Mon Mar 31 17:55:11 GMT 2025
|
PRIMARY | RxNorm | ||
|
205-337-9
Created by
admin on Mon Mar 31 17:55:11 GMT 2025 , Edited by admin on Mon Mar 31 17:55:11 GMT 2025
|
PRIMARY | |||
|
951
Created by
admin on Mon Mar 31 17:55:11 GMT 2025 , Edited by admin on Mon Mar 31 17:55:11 GMT 2025
|
PRIMARY | |||
|
K294OAI79V
Created by
admin on Mon Mar 31 17:55:11 GMT 2025 , Edited by admin on Mon Mar 31 17:55:11 GMT 2025
|
PRIMARY | |||
|
DTXSID20858964
Created by
admin on Mon Mar 31 17:55:11 GMT 2025 , Edited by admin on Mon Mar 31 17:55:11 GMT 2025
|
PRIMARY | |||
|
C62098
Created by
admin on Mon Mar 31 17:55:11 GMT 2025 , Edited by admin on Mon Mar 31 17:55:11 GMT 2025
|
PRIMARY | |||
|
138-65-8
Created by
admin on Mon Mar 31 17:55:11 GMT 2025 , Edited by admin on Mon Mar 31 17:55:11 GMT 2025
|
PRIMARY | |||
|
m8054
Created by
admin on Mon Mar 31 17:55:11 GMT 2025 , Edited by admin on Mon Mar 31 17:55:11 GMT 2025
|
PRIMARY | Merck Index | ||
|
294898
Created by
admin on Mon Mar 31 17:55:11 GMT 2025 , Edited by admin on Mon Mar 31 17:55:11 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
METABOLITE -> PARENT |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |